Go Pro
→ A letter from Shannon Stansberry (From Porter & Company) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
$0.00
$0.00
▼
$0.05
N/AN/AN/AN/A
ARHCF
Alfresa
$14.00
$12.79
$14.00
▼
$14.59
N/AN/A2,750 shsN/A
CHCR
Advanzeon Solutions
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$9.81
+0.2%		$10.66
$9.76
▼
$14.87
N/AN/A89,651 shs141,465 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
0.00%0.00%0.00%0.00%0.00%
ARHCF
Alfresa
0.00%0.00%+17.94%+17.94%+17.94%
CHCR
Advanzeon Solutions
0.00%0.00%0.00%0.00%0.00%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
-2.68%-5.50%-11.56%-9.52%-18.35%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
$0.00
$0.00
▼
$0.05
N/AN/AN/AN/A
ARHCF
Alfresa
$14.00
$12.79
$14.00
▼
$14.59
N/AN/A2,750 shsN/A
CHCR
Advanzeon Solutions
$0.00
$0.00
▼
$0.00
N/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
$9.81
+0.2%		$10.66
$9.76
▼
$14.87
N/AN/A89,651 shs141,465 shs
7 Best Space Stocks to Own in 2026 Cover
7 Best Space Stocks to Own in 2026

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
0.00%0.00%0.00%0.00%0.00%
ARHCF
Alfresa
0.00%0.00%+17.94%+17.94%+17.94%
CHCR
Advanzeon Solutions
0.00%0.00%0.00%0.00%0.00%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
-2.68%-5.50%-11.56%-9.52%-18.35%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
0.00
N/AN/AN/A
ARHCF
Alfresa
0.00
N/AN/AN/A
CHCR
Advanzeon Solutions
0.00
N/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/AN/AN/AN/AN/AN/A
ARHCF
Alfresa
N/AN/AN/AN/AN/AN/A
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/AN/AN/AN/AN/AN/AN/AN/AN/A
ARHCF
Alfresa
N/AN/AN/AN/AN/AN/AN/AN/AN/A
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A$4.991.97N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/AN/AN/AN/AN/A
ARHCF
Alfresa
N/AN/AN/AN/AN/A
CHCR
Advanzeon Solutions
N/AN/AN/AN/AN/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/AN/AN/AN/AN/A

Institutional Ownership

CompanyInstitutional Ownership
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
N/A
ARHCF
Alfresa
N/A
CHCR
Advanzeon Solutions
N/A
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A

Insider Ownership

CompanyInsider Ownership
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
11.50%
ARHCF
Alfresa
N/A
CHCR
Advanzeon Solutions
16.50%
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
N/A
CompanyEmployeesShares OutstandingFree FloatOptionable
Aeon Global Health Corp stock logo
AGHC
Aeon Global Health
52N/AN/ANot Optionable
ARHCF
Alfresa
11,772N/AN/ANot Optionable
CHCR
Advanzeon Solutions
2N/AN/ANot Optionable
Sinopharm Group Co. Ltd. stock logo
SHTDY
Sinopharm Group
115,959N/AN/ANot Optionable

Recent News About These Companies

SHTDY - Sinopharm Group Co. Ltd.
August 26, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/SHTDY/dividends/dividend-safety
Sinopharm Group (SHTDY) Expected to Announce Quarterly Earnings on Monday
August 24, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30979288
SINOPHARM GRP CO UNSP/ADR by Sinopharm Group Co. Ltd. Stock Short Interest Report | OTC:SHTDY | Benzinga
July 23, 2026  |  benzinga.comhttps://www.benzinga.com/quote/SHTDY/short-interest
Sinopharm Group Announces Executive Director Changes
November 6, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/sinopharm-group-announces-executive-director-changes/ar-AA1PVm5Y
Sinopharm Group Schedules Board Meeting to Review Interim Results
August 13, 2025  |  msn.comhttps://www.msn.com/en-us/money/markets/sinopharm-group-schedules-board-meeting-to-review-interim-results/ar-AA1Kni8a
Sinopharm Group Co. Ltd. ADR (SHTDY) Stock Price Today - WSJ
July 17, 2025  |  wsj.comhttps://www.wsj.com/market-data/quotes/SHTDY
Sinopharm Group Updates Final Dividend Distribution for 2024
June 12, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-group-updates-final-dividend-distribution-for-2024?utm_source=marketbeat.com&utm_medium=referral
Sinopharm Group Co. Ltd. Reports Successful AGM and Shareholder Meetings
June 12, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-group-co-ltd-reports-successful-agm-and-shareholder-meetings?utm_source=marketbeat.com&utm_medium=referral
Study: Sinopharm COVID-19 vaccines appear safe, effective
May 12, 2025  |  asahi.comA
Sinopharm Group Reports Q1 2025 Financial Results
April 27, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-group-reports-q1-2025-financial-results?utm_source=marketbeat.com&utm_medium=referral
Sinopharm Accord Reports Q1 2025 Financial Results with Declines in Revenue and Profit
April 24, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-accord-reports-q1-2025-financial-results-with-declines-in-revenue-and-profit?utm_source=marketbeat.com&utm_medium=referral
Sinopharm Group’s 2024 Transformation and Innovation Drive
March 23, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-groups-2024-transformation-and-innovation-drive?utm_source=marketbeat.com&utm_medium=referral
Sinopharm’s CNMDC Reports Decline in 2024 Financial Performance
March 20, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharms-cnmdc-reports-decline-in-2024-financial-performance?utm_source=marketbeat.com&utm_medium=referral
Sinopharm Reports Mixed Financial Results for 2024
March 19, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-reports-mixed-financial-results-for-2024?utm_source=marketbeat.com&utm_medium=referral
Some 47 Chinese workers in Uganda inoculated with the Sinopharm vaccine allegedly tested positive
January 30, 2025  |  en.mercopress.comE
3 Compelling Dividend Stocks Offering Yields Up To 5.1%
January 28, 2025  |  finance.yahoo.comhttps://finance.yahoo.com/news/3-compelling-dividend-stocks-offering-050606806.html
Sinopharm Group Schedules EGM for Board Director Appointments
January 19, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-group-schedules-egm-for-board-director-appointments?utm_source=marketbeat.com&utm_medium=referral
Sinopharm Accord Projects Notable Profit Decline for 2024
January 19, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-accord-projects-notable-profit-decline-for-2024?utm_source=marketbeat.com&utm_medium=referral
Sinopharm Group Proposes New Director Appointments
January 8, 2025  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/sinopharm-group-proposes-new-director-appointments?utm_source=marketbeat.com&utm_medium=referral
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Sinopharm Group Co (OtherSHTDF)
December 12, 2024  |  markets.businessinsider.comhttps://markets.businessinsider.com/news/stocks/analysts-offer-insights-on-healthcare-companies-biolife-solutions-blfs-and-sinopharm-group-co-othershtdf-1034128815

Media Sentiment Over Time

Aeon Global Health stock logo

Aeon Global Health OTCMKTS:AGHC

AEON Global Health Corp. is a growth oriented provider of personalized, actionable medical informatics, and telemedicine. It offers a comprehensive menu of diagnostic and laboratory developed assays, as well as interpretive data for a range of inherited conditions. The company was founded by Hanif A. Roshan and Shawn Desai in August 1985 and is headquartered in Gainesville, GA.

Alfresa OTCMKTS:ARHCF

$14.00 0.00 (0.00%)
As of 08/28/2026

Alfresa Holdings Corporation, through its subsidiaries, engages in the manufacture, wholesale, marketing, and import/export of pharmaceuticals, diagnostic reagents, and medical devices/equipment in Japan and internationally. It is involved in the ethical pharmaceuticals wholesaling business that offers diagnostic reagents and medical devices/equipment to hospitals, clinics, and dispensing pharmacies. The company also engages in self-medication products wholesaling business that offers over-the-counter drugs, including health foods, supplements, and other products to drug stores and pharmacies. In addition, it manufactures and markets active pharmaceutical ingredients, pharmaceuticals, diagnostic reagents, and medical devices, as well as undertakes contract manufacturing of pharmaceuticals. Further, the company's medical-related business includes its dispensing pharmacy and other medical-related businesses. The company was incorporated in 2003 and is based in Tokyo, Japan.

Advanzeon Solutions OTCMKTS:CHCR

Advanzeon Solutions, Inc., through its subsidiary, Pharmacy Value Management Solutions, Inc., administers and operates a sleep apnea program known as SleepMaster Solutions. The company was formerly known as Comprehensive Care Corporation and changed its name to Advanzeon Solutions, Inc. in January 2014. Advanzeon Solutions, Inc. was founded in 1969 and is headquartered in Tampa, Florida. On September 8, 2022, the voluntary petition of Advanzeon Solutions, Inc. for reorganization under Chapter 11 was converted to Chapter 7. It had filed for Chapter 11 bankruptcy on September 7, 2020.

Sinopharm Group stock logo

Sinopharm Group OTCMKTS:SHTDY

$9.81 +0.02 (+0.20%)
As of 03:58 PM Eastern

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas